NCT03112252

Brief Summary

App-based study of allergy patients under medication in the pollen season to determine the effect of allergic rhinitis on the quality of life.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
173

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Apr 2017

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

March 30, 2017

Completed
14 days until next milestone

First Posted

Study publicly available on registry

April 13, 2017

Completed
6 days until next milestone

Study Start

First participant enrolled

April 19, 2017

Completed
4 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 31, 2017

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

August 31, 2017

Completed
Last Updated

October 25, 2017

Status Verified

October 1, 2017

Enrollment Period

4 months

First QC Date

March 30, 2017

Last Update Submit

October 24, 2017

Conditions

Keywords

Immunotherapy

Outcome Measures

Primary Outcomes (1)

  • allergic symptoms of patients

    allergic symptoms of patients during the pollen season

    one month

Interventions

patients with allergic rhinitis

Eligibility Criteria

Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

patients with allergic rhinitis

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Institute of Medical Statistics, Informatics and Epidemiology

Cologne, North Rhine-Westphalia, 50931, Germany

Location

MeSH Terms

Conditions

Rhinitis, Allergic

Condition Hierarchy (Ancestors)

RhinitisNose DiseasesRespiratory Tract DiseasesRespiratory HypersensitivityOtorhinolaryngologic DiseasesHypersensitivity, ImmediateHypersensitivityImmune System Diseases

Study Officials

  • Ralph Mösges, Prof. Dr.

    University Hospital of Cologne

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
OTHER
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Prof. Dr.

Study Record Dates

First Submitted

March 30, 2017

First Posted

April 13, 2017

Study Start

April 19, 2017

Primary Completion

August 31, 2017

Study Completion

August 31, 2017

Last Updated

October 25, 2017

Record last verified: 2017-10

Data Sharing

IPD Sharing
Will not share

Locations